A Study of the Hepatic Tolerance of the Ethyl Acetate Fraction of Morinda morindoides (Baker) Milne- Redhead (Rubiaceae) Extract in Rabbit
AbstractPurpose: In this study, the effect of the ethyl acetate fraction of the extract of Morinda morindoides (Baker) Milne-Redhead (Rubiaceae) on the tissue and metabolic integrity of rabbit liver was evaluated.
Methods: Thirty rabbits (divided equally between male and female) were randomly distributed into five (5) groups of six (6) rabbits each. These animals received, by intraperitoneal injection, twice a week the ethyl acetate fraction (F1) of the hydroalcohol extract of Morinda morindoides in doses ranging from 25 to 100 ƒÊg/kg body weight for Groups 2 (Gp2) to 5 (Gp5) while Group 1 (Gp1) and control, received 1 ml of MacEwen physiological fluid. Blood sampling was carried out to evaluate various parameters: alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gammaglutamyltransferase (GT), lactate dehydrogenase (LDH), total cholesterol, HDL cholesterol, triglycerides, glucose and total proteins
Results: Analysis of the parameters following administration of the extract fraction showed slight increases in AST and ALT activities as well as the concentrations of total cholesterol and glucose, compared to their initial values. On the other hand, protein, glyceride, total cholesterol and high density lipoprotein cholesterol levels as well as the activities of ALP, GT and the LDH did not change significantly (p >0.05). Nevertheless, the changes observed during the study were within the limits of the normal values for these various parameters in rabbit.
Conclusion: These results revealed that the ethyl acetate fraction (F1) of the hydroalchol extract of Morinda morindoides, when used in the dose range evaluated in this study, may be well tolerated by the liver.
Keywords: Hepatic tolerance, Morinda morindoides, Serum biochemical parameters
Tropical Journal of Pharmaceutical Research December 2010; 9 (6): 573-579
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.